| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| May 7, 2026 | ±2.3% | -21.5% | under-priced |
| November 4, 2025 | ±1.7% | -13.8% | under-priced |
| August 5, 2025 | ±2.3% | -3.8% | under-priced |
| May 6, 2025 | ±2.5% | -5.2% | under-priced |
| November 4, 2024 | ±2.1% | -3.7% | under-priced |
| August 6, 2024 | ±2.9% | +6.0% | under-priced |
| May 2, 2024 | ±2.8% | +5.5% | under-priced |
| November 2, 2023 | ±2.9% | +6.3% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2026 | $1.42 | $2.3B | $601M |
| Q4 FY2025 | $1.37 | $2.4B | $603M |
| Q3 FY2025 | $1.63 | $2.4B | $721M |
| Q2 FY2025 | $1.61 | $2.5B | $718M |
ZOETIS INC. (ZTS) reports in 100 days, with the next report estimated for September 21, 2026. Across the last 8 reports, options priced an average ±2.4% earnings move while the stock actually moved 8.2% on average — the market has tended to under-price ZTS's earnings risk. Fundamentals into the print: EPS up 0.7% year-over-year, revenue up 1.9%. QuantLogix's live 5-factor engine currently reads ZTS as a neutral at 44/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →